{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:49:01Z","timestamp":1773856141717,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00059-016-4530-5","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T20:34:11Z","timestamp":1484858051000},"page":"107-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kardiales Remodelling nach Myokardinfarkt","Cardiac remodeling after myocardial infarction"],"prefix":"10.1007","volume":"42","author":[{"given":"G.","family":"Ertl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Angermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"issue":"8","key":"4530_CR1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et\u00a0al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891\u2013975","journal-title":"Eur J Heart Fail"},{"key":"4530_CR2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-9149(60)90084-9","volume":"5","author":"AJ Linzbach","year":"1960","unstructured":"Linzbach AJ (1960) Heart failure from the point of view of quantitative anatomy. Am J Cardiol 5:370\u2013382","journal-title":"Am J Cardiol"},{"key":"4530_CR3","first-page":"H1406","volume":"260","author":"JM Pfeffer","year":"1991","unstructured":"Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E (1991) Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 260:H1406\u2013H1414","journal-title":"Am J Physiol"},{"key":"4530_CR4","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/01.CIR.87.3.755","volume":"87","author":"P Gaudron","year":"1993","unstructured":"Gaudron P, Eilles C, Kugler I, Ertl G (1993) Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 87:755\u2013763","journal-title":"Circulation"},{"key":"4530_CR5","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.CIR.86.6.1810","volume":"86","author":"S Neubauer","year":"1992","unstructured":"Neubauer S, Krahe T, Schindler R et al (1992) 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86:1810\u20131818","journal-title":"Circulation"},{"key":"4530_CR6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1172\/JCI117756","volume":"95","author":"S Neubauer","year":"1995","unstructured":"Neubauer S, Horn M, Naumann A et\u00a0al (1995) Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J\u00a0Clin Invest 95:1092\u20131100","journal-title":"J Clin Invest"},{"key":"4530_CR7","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","volume":"96","author":"S Neubauer","year":"1997","unstructured":"Neubauer S, Horn M, Cramer M et al (1997) Myocardial phosphocreatine-to-ATP ratio is a\u00a0predictor of mortality in patients with dilated cardiomyopathy. Circulation 96:2190\u20132196","journal-title":"Circulation"},{"key":"4530_CR8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1172\/JCI200318611","volume":"111","author":"B Nadal-Ginard","year":"2003","unstructured":"Nadal-Ginard B, Kajstura J, Anversa P, Leri A (2003) A\u00a0matter of life and death: cardiac myocyte apoptosis and regeneration. J Clin Invest 111:1457\u20131459","journal-title":"J Clin Invest"},{"key":"4530_CR9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum T, Galuppo P, Wolf C et\u00a0al (2007) MicroRNAs in the human heart: a\u00a0clue to fetal gene reprogramming in heart failure. Circulation 116:258\u2013267","journal-title":"Circulation"},{"key":"4530_CR10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/CIRCULATIONAHA.112.138313","volume":"126","author":"G Ertl","year":"2012","unstructured":"Ertl G, Frantz S (2012) Adverse cardiac remodeling: phosphoinositide 3\u2011kinase, another unique factor in a\u00a0multifactorial condition. Circulation 126:2175\u20132176","journal-title":"Circulation"},{"key":"4530_CR11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.01.011","volume":"66","author":"G Ertl","year":"2005","unstructured":"Ertl G, Frantz S (2005) Healing after myocardial infarction. Cardiovasc Res 66:22\u201332","journal-title":"Cardiovasc. Res."},{"key":"4530_CR12","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/CIRCULATIONAHA.111.044164","volume":"125","author":"U Hofmann","year":"2012","unstructured":"Hofmann U, Beyersdorf N, Weirather J et\u00a0al (2012) Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 125:1652\u20131663","journal-title":"Circulation"},{"key":"4530_CR13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/01.CIR.103.11.1564","volume":"103","author":"C Waller","year":"2001","unstructured":"Waller C, Hiller KH, Kahler E et\u00a0al (2001) Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart. Circulation 103:1564\u20131569","journal-title":"Circulation"},{"key":"4530_CR14","doi-asserted-by":"crossref","first-page":"7D","DOI":"10.1016\/0002-9149(91)90256-K","volume":"68","author":"P Anversa","year":"1991","unstructured":"Anversa P, Olivetti G, Capasso JM (1991) Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 68:7D\u201316D","journal-title":"Am J Cardiol"},{"key":"4530_CR15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.111.039008","volume":"124","author":"J Fiedler","year":"2011","unstructured":"Fiedler J, Jazbutyte V, Kirchmaier BC et al (2011) MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124:720\u2013730","journal-title":"Circulation"},{"key":"4530_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu SD, Frangogiannis NG (2016) The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 119:91\u2013112","journal-title":"Circ Res"},{"key":"4530_CR17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jacc.2009.08.038","volume":"55","author":"G Ertl","year":"2010","unstructured":"Ertl G, Thum T (2010) New insight into healing mechanisms of the infarcted heart. J\u00a0Am Coll Cardiol 55:144\u2013146","journal-title":"J Am Coll Cardiol"},{"key":"4530_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cardiores.2006.01.002","volume":"70","author":"T Thum","year":"2006","unstructured":"Thum T, Fraccarollo D, Galuppo P et\u00a0al (2006) Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. Cardiovasc Res 70:50\u201360","journal-title":"Cardiovasc Res"},{"key":"4530_CR19","first-page":"H312","volume":"270","author":"K Hu","year":"1996","unstructured":"Hu K, Gaudron P, Bahner U et\u00a0al (1996) Changes of atrial natriuretic peptide in brain areas of rats with chronic myocardial infarction. Am J Physiol 270:H312\u2013H316","journal-title":"Am J Physiol"},{"key":"4530_CR20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fnbeh.2014.00376","volume":"8","author":"A Frey","year":"2014","unstructured":"Frey A, Popp S, Post A et al (2014) Experimental heart failure causes depression-like behavior together with differential regulation of inflammatory and structural genes in the brain. Front Behav Neurosci 8:376","journal-title":"Front Behav Neurosci"},{"key":"4530_CR21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s003950170056","volume":"96","author":"K Hu","year":"2001","unstructured":"Hu K, Bahner U, Gaudron P et al (2001) Chronic effects of ACE-inhibition (quinapril) and angiotensin-II-type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction. Basic Res Cardiol 96:258\u2013266","journal-title":"Basic Res Cardiol"},{"key":"4530_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1\u201339.e14","journal-title":"J Am Soc Echocardiogr"},{"key":"4530_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0735-1097(85)80419-8","volume":"5","author":"H Blanke","year":"1985","unstructured":"Blanke H, Cohen M, Karsch KR et\u00a0al (1985) Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction. J\u00a0Am Coll Cardiol 5:827\u2013831","journal-title":"J Am Coll Cardiol"},{"key":"4530_CR24","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.88.4.1527","volume":"88","author":"IP Clements","year":"1993","unstructured":"Clements IP, Christian TF, Higano ST et\u00a0al (1993) Residual flow to the infarct zone as a\u00a0determinant of infarct size after direct angioplasty. Circulation 88:1527\u20131533","journal-title":"Circulation"},{"key":"4530_CR25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","volume":"369","author":"DS Wald","year":"2013","unstructured":"Wald DS, Morris JK, Wald NJ et\u00a0al (2013) Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 369:1115\u20131123","journal-title":"N Engl J Med"},{"key":"4530_CR26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","volume":"65","author":"AH Gershlick","year":"2015","unstructured":"Gershlick AH, Khan JN, Kelly DJ et al (2015) Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 65:963\u2013972","journal-title":"J Am Coll Cardiol"},{"key":"4530_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002142","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Toklu B, Wetterslev J (2015) Complete versus culprit-only revascularization for ST-segment-elevation myocardial infarction and multivessel disease: a\u00a0meta-analysis and trial sequential analysis of randomized trials. Circ Cardiovasc Interv. doi: 10.1161\/CIRCINTERVENTIONS.114.002142","journal-title":"Circ Cardiovasc Interv"},{"key":"4530_CR28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.65.1.40","volume":"65","author":"G Ertl","year":"1982","unstructured":"Ertl G, Kloner RA, Alexander RW, Braunwald E (1982) Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor. Circulation 65:40\u201348","journal-title":"Circulation"},{"key":"4530_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.RES.57.1.84","volume":"57","author":"JM Pfeffer","year":"1985","unstructured":"Pfeffer JM, Pfeffer MA, Braunwald E (1985) Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57:84\u201395","journal-title":"Circ Res"},{"key":"4530_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM198807143190204","volume":"319","author":"MA Pfeffer","year":"1988","unstructured":"Pfeffer MA, Lamas GA, Vaughan DE et\u00a0al (1988) Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319:80\u201386","journal-title":"N Engl J Med"},{"key":"4530_CR31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.CIR.72.2.406","volume":"72","author":"MA Pfeffer","year":"1985","unstructured":"Pfeffer MA, Pfeffer JM, Steinberg C, Finn P (1985) Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72:406\u2013412","journal-title":"Circulation"},{"key":"4530_CR32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"MA Pfeffer","year":"1992","unstructured":"Pfeffer MA, Braunwald E, Moye LA et\u00a0al (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669\u2013677","journal-title":"N Engl J Med"},{"key":"4530_CR33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","volume":"327","author":"The SOLVD Investigattors","year":"1992","unstructured":"The SOLVD Investigattors (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685\u2013691","journal-title":"N Engl J Med"},{"key":"4530_CR34","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.CIR.91.10.2573","volume":"91","author":"B Greenberg","year":"1995","unstructured":"Greenberg B, Quinones MA, Koilpillai C et al (1995) Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 91:2573\u20132581","journal-title":"Circulation"},{"key":"4530_CR35","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ et\u00a0al (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893\u20131906","journal-title":"N Engl J Med"},{"key":"4530_CR36","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/euhj.1998.1481","volume":"20","author":"BA Bart","year":"1999","unstructured":"Bart BA, Ertl G, Held P et\u00a0al (1999) Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J 20:1182\u20131190","journal-title":"Eur Heart J"},{"key":"4530_CR37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","volume":"362","author":"CB Granger","year":"2003","unstructured":"Granger CB, McMurray JJ, Yusuf S et al (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362:772\u2013776","journal-title":"Lancet"},{"key":"4530_CR38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0735-1097(97)00012-0","volume":"29","author":"RN Doughty","year":"1997","unstructured":"Doughty RN, Whalley GA, Gamble G et al (1997) Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol 29:1060\u20131066","journal-title":"J Am Coll Cardiol"},{"key":"4530_CR39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","volume":"109","author":"RN Doughty","year":"2004","unstructured":"Doughty RN, Whalley GA, Walsh HA et\u00a0al (2004) Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 109:201\u2013206","journal-title":"Circulation"},{"key":"4530_CR40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","volume":"39","author":"J Bauersachs","year":"2002","unstructured":"Bauersachs J, Heck M, Fraccarollo D et al (2002) Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. J Am Coll Cardiol 39:351\u2013358","journal-title":"J Am Coll Cardiol"},{"key":"4530_CR41","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","volume":"42","author":"D Fraccarollo","year":"2003","unstructured":"Fraccarollo D, Galuppo P, Hildemann S et\u00a0al (2003) Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction. J\u00a0Am Coll Cardiol 42:1666\u20131673","journal-title":"J Am Coll Cardiol"},{"key":"4530_CR42","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.110.983023","volume":"123","author":"D Fraccarollo","year":"2011","unstructured":"Fraccarollo D, Berger S, Galuppo P et\u00a0al (2011) Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 123:400\u2013408","journal-title":"Circulation"},{"key":"4530_CR43","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"M Hayashi","year":"2003","unstructured":"Hayashi M, Tsutamoto T, Wada A et al (2003) Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a\u00a0marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 107:2559\u20132565","journal-title":"Circulation"},{"key":"4530_CR44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5847\/wjem.j.issn.1920-8642.2013.01.009","volume":"4","author":"CT Wu","year":"2013","unstructured":"Wu CT, Wang ZH, Li ZQ, Wang LF (2013) Effect of spironolactone on cardiac remodeling after acute myocardial infarction. World J Emerg Med 4:48\u201353","journal-title":"World J Emerg Med"},{"key":"4530_CR45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0008-6363(98)00310-1","volume":"41","author":"K Hu","year":"1999","unstructured":"Hu K, Ertl G (1999) Potential role of mixed ACE and neutral endopeptidase inhibitor in the treatment of heart failure. Cardiovasc Res 41:503\u2013505","journal-title":"Cardiovasc Res"},{"key":"4530_CR46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","volume":"8","author":"TG Lueder von","year":"2015","unstructured":"von Lueder TG, Wang BH, Kompa AR et\u00a0al (2015) Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ Heart Fail 8:71\u201378","journal-title":"Circ Heart Fail"},{"key":"4530_CR47","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1056\/NEJMoa043938","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, Zelenkofske S, McMurray JJ et\u00a0al (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352:2581\u20132588","journal-title":"N Engl J Med"},{"key":"4530_CR48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.115.019124","volume":"134","author":"NK Wassnig","year":"2016","unstructured":"Wassnig NK, Gunther M, Quick S et al (2016) Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation 134:635\u2013643","journal-title":"Circulation"},{"key":"4530_CR49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ejheart.2005.11.007","volume":"8","author":"L Kober","year":"2006","unstructured":"Kober L, Swedberg K, McMurray JJ et\u00a0al (2006) Previously known and newly diagnosed atrial fibrillation: a\u00a0major risk indicator after a\u00a0myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 8:591\u2013598","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"4530_CR50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ejhf.252","volume":"17","author":"G Guder","year":"2015","unstructured":"Guder G, Stork S, Gelbrich G et al (2015) Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail 17(4):442\u2013452","journal-title":"Eur J Heart Fail"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-016-4530-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-016-4530-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-016-4530-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T08:38:31Z","timestamp":1498379911000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-016-4530-5"}},"subtitle":["Update f\u00fcr die klinische Praxis","Clinical practice update"],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4530"],"URL":"https:\/\/doi.org\/10.1007\/s00059-016-4530-5","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}